SiO2 and ZnO dopants in three-dimensionally printed tricalcium phosphate bone tissue engineering scaffolds enhance osteogenesis and angiogenesis in vivo
Source abstract
Abstract
Calcium phosphate (CaP) scaffolds with three-dimensionally-interconnected pores play an important role in mechanical interlocking and biological fixation in bone implant applications. CaPs alone, however, are only osteoconductive (able to guide bone growth). Much attention has been given to the incorporation of biologics and pharmacologics to add osteoinductive (able to cause new bone growth) properties to CaP materials. Because biologics and pharmacologics are generally delicate compounds and also subject to increased regulatory scrutiny, there is a need to investigate alternative methods to introduce osteoinductivity to CaP materials. In this study silica (SiO2) and zinc oxide (ZnO) have been incorporated into three-dimensional printed β-tricalcium phosphate (β-TCP) scaffolds to investigate their potential to trigger osteoinduction in vivo. Silicon and zinc are trace elements that are common in bone and have also been shown to have many beneficial properties, from increased bone regeneration to angiogenesis. Implants were placed in bicortical femur defects introduced to a murine model for up to 16 weeks. The addition of dopants into TCP increased the capacity for new early bone formation by modulating collagen I production and osteocalcin production. Neovascularization was found to be up to three times more than the pure TCP control group. The findings from this study indicate that the combination of SiO2 and ZnO dopants in TCP may be a viable alternative to introducing osteoinductive properties to CaPs.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Orthopaedic implants and arthroplasty · Dental Implant Techniques and Outcomes
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (57)
Show source-provided references
1. 2001 · 893
2. Calcium phosphate ceramic systems in growth factor and drug delivery for bone tissue engineering—a review10.1016/j.actbio.2011.11.017 ↗
3. Histological and histomorphometrical comparative study of the degradation and osteoconductive characteristics of α- and β-tricalcium phosphate in block grafts10.1002/jbm.b.30715 ↗
4. Mechanisms of endosseous integration
5. Porous scaffold design for tissue engineering10.1038/nmat1421 ↗
6. Direct write assembly of calcium phosphate scaffolds using a water-based hydrogel
7. 3D powder printing of β-tricalcium phosphate ceramics using different strategies10.1002/adem.200800179 ↗
8. Development of a new calcium phosphate powder-binder system for the 3D printing of patient specific implants10.1007/s10856-006-0073-2 ↗
9. Effects of SiO2 and ZnO doping on mechanical and biological properties of 3D printed TCP scaffolds10.1016/j.dental.2011.09.010 ↗
10. Osteoinduction, osteoconduction and osseointegration
11. 3D microenvironment as essential element for osteoinduction by biomaterials10.1016/j.biomaterials.2004.09.056 ↗
12. The effects of microporosity on osteoinduction of calcium phosphate bone graft substitute biomaterials10.1016/j.actbio.2012.03.038 ↗
13. Pore throat size and connectivity determine bone and tissue ingrowth into porous implants: three-dimensional micro-CT based structural analyses of porous bioactive titanium implants10.1016/j.biomaterials.2006.08.013 ↗
14. Effect of nanostructure on osteoinduction of porous biphasic calcium phosphate ceramics10.1016/j.actbio.2012.06.021 ↗
15. Modification of apatite materials for bone tissue engineering and drug delivery carriers10.2174/092986707782023208 ↗
16. Bone response to calcium phosphate-coated and bisphosphonate-immobilized titanium implants10.1016/S0142-9612(01)00415-X ↗
17. Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow10.1210/endo.138.10.5425 ↗
18. The effect of BMP-2 on micro- and macroscale osteointegration of biphasic calcium phosphate scaffolds with multiscale porosity10.1016/j.actbio.2010.02.026 ↗
19. Silicon-substituted calcium phosphates–a critical view10.1016/j.biomaterials.2009.08.007 ↗
20. 3D printed tricalcium phosphate bone tissue engineering scaffolds: effect of SrO and MgO doping on in vivo osteogenesis in a rat distal femoral defect model10.1039/c3bm60132c ↗
21. Calcium phosphate-based resorbable ceramics: influence of MgO, ZnO, and SiO2 dopants10.1111/j.1551-2916.2006.01207.x ↗
22. Understanding in vivo response and mechanical property variation in MgO, SrO and SiO2 doped β-TCP10.1016/j.bone.2011.03.685 ↗
23. Understanding the influence of MgO and SrO binary doping on the mechanical and biological properties of [beta]-TCP ceramics10.1016/j.actbio.2010.05.012 ↗
24. Enhanced in vitro cell activity on silicon-doped vaterite/poly (lactic acid) composites10.1016/j.actbio.2008.08.004 ↗
25. Engineering of bone using bone marrow stromal cells and a silicon-stabilized tricalcium phosphate bioceramic: evidence for a coupling between bone formation and scaffold resorption10.1016/j.biomaterials.2006.10.001 ↗
26. Silicon substitution in the calcium phosphate bioceramics10.1016/j.biomaterials.2007.05.003 ↗
27. Effects of silicon, fluoride, etidronate and magnesium on bone mineral density: a retrospective study
28. Human osteoblast response to silicon-substituted hydroxyapatite10.1002/jbm.a.30806 ↗
29. Role of nutritional zinc in the prevention of osteoporosis10.1007/s11010-009-0358-0 ↗
30. Zinc stimulates osteoblastogenesis and suppresses osteoclastogenesis by antagonizing NF-κB activation10.1007/s11010-011-0852-z ↗
31. Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation10.1016/j.bone.2009.11.003 ↗
32. Effect of zinc on gene expression in osteoblastic MC3T3-E1 cells: enhancement of Runx2, OPG, and regucalcin mRNA expressions10.1007/s11010-008-9731-7 ↗
33. Trace elements and postmenopausal osteoporosis: a preliminary study of decreased serum manganese
34. Synthesis and characterization of tricalcium phosphate with Zn and Mg based dopants10.1007/s10856-008-3395-4 ↗
35. Bone histomorphometry using free and commonly available software10.1111/j.1365-2559.2012.04333.x ↗
36. Effects of pore shape and porosity on the properties of porous LNKN ceramics as bone substitute10.1016/j.matchemphys.2007.12.022 ↗
37. The effect of pore geometry on the in vitro biological behavior of human periosteum-derived cells seeded on selective laser-melted Ti6Al4V bone scaffolds10.1016/j.actbio.2012.04.001 ↗
38. Synthesis and characterization of porous beta-tricalcium phosphate blocks10.1016/j.biomaterials.2005.03.026 ↗
39. Microwave-sintered 3D printed tricalcium phosphate scaffolds for bone tissue engineering
40. Analysis of the roles of microporosity and BMP-2 on multiple measures of bone regeneration and healing in calcium phosphate scaffolds10.1016/j.actbio.2010.12.030 ↗
41. Dietary zinc reduces osteoclast resorption activities and increases markers of osteoblast differentiation, matrix maturation, and mineralization in the long bones of growing rats10.1016/j.jnutbio.2009.01.002 ↗
42. Zinc deficiency decreases osteoblasts and osteoclasts associated with the reduced expression of Runx2 and RANK10.1016/j.bone.2011.08.019 ↗
43. Silicon: the key element in early stages of biocalcification10.1016/j.jsb.2010.09.025 ↗
44. Effect of silicon level on rate, quality and progression of bone healing within silicate-substituted porous hydroxyapatite scaffolds10.1016/j.biomaterials.2006.05.039 ↗
45. Flow perfusion culture of human mesenchymal stem cells on silicate-substituted tricalcium phosphate scaffolds10.1016/j.biomaterials.2008.03.003 ↗
46. Effects of exogenous phosphorus and silicon on osteoblast differentiation at the interface with bioactive ceramics10.1002/jbm.a.32915 ↗
47. Aspects of collagen mineralization in hard tissue formation10.1016/S0074-7696(04)42003-8 ↗
48. Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone10.1016/j.ejphar.2011.07.003 ↗
49. Silicon deprivation decreases collagen formation in wounds and bone, and ornithine transaminase enzyme activity in liver10.1385/BTER:89:3:251 ↗
50. Expression of matrix proteins during the development of mineralized tissues10.1016/S8756-3282(96)00218-9 ↗
51. Effect of β-alanyl-L-histidinato zinc on protein components in osteoblastic MC3T3-El cells: increase in osteocalcin, insulin-like growth factor-I and transforming growth factor-β10.1007/BF00926077 ↗
52. Enhanced osteocalcin expression by osteoblast-like cells (MC3T3-E1) exposed to bioactive coating glass (SiO2–CaO–P2O5–MgO–K2O–Na2O system) ions10.1016/j.actbio.2009.05.035 ↗
53. A calcium-induced signaling cascade leading to osteogenic differentiation of human bone marrow-derived mesenchymal stromal cells10.1016/j.biomaterials.2012.01.020 ↗
54. Silicate bioceramics induce angiogenesis during bone regeneration10.1016/j.actbio.2011.09.008 ↗
55. Up-regulation by zinc of FGF-2-induced VEGF release throughenhancing p44/p42 MAP kinase activation in osteoblasts10.1016/j.lfs.2006.09.003 ↗
56. Osteoblast-mediated effects of zinc on isolated rat osteoclasts: inhibition of bone resorption and enhancement of osteoclast number10.1016/8756-3282(96)00141-X ↗
57. Bioactive silica-based nanoparticles stimulate bone-forming osteoblasts, suppress bone-resorbing osteoclasts, and enhance bone mineral density in vivo10.1016/j.nano.2011.11.003 ↗